Teenagers from 15 should be given free MenB vaccine, say UK experts

UK Experts Recommend Free MenB Vaccination for Teenagers Starting at 15

Teenagers from 15 should be given - Following a significant meningitis B outbreak in Kent earlier this year, UK health authorities have revised their guidelines to suggest that all adolescents aged 15 should receive a free MenB vaccine. This marks a shift from earlier recommendations, which did not include this age group. The updated advice aims to address the growing concern over the disease’s prevalence among teenagers.

A temporary vaccination initiative is set to commence this summer, targeting university-bound youth and others. Officials are now urging the government to consider incorporating MenB shots into routine immunization programs for secondary school students. The NHS would cover the cost, ensuring no out-of-pocket expenses for recipients.

The Kent Outbreak and Public Response

During the outbreak, 29 confirmed or suspected cases were reported, with two fatalities. This prompted a surge in private vaccinations as parents rushed to protect their children. Initially, the government and JCVI deemed broader teen vaccination unnecessary. However, new evidence has led to a change in stance, acknowledging that teenagers are more susceptible to contracting the disease.

"The only thing that could have saved Aaron is the vaccine," said Anthony Mills, whose 18-year-old son died from MenB during a holiday break. Mills emphasized that his son’s legacy is now a call to action for wider vaccination. The family has since focused on raising awareness for Meningitis Now, highlighting the need for better public education.

Meningitis B can cause severe complications, including brain inflammation and blood poisoning. It may lead to amputations, hearing loss, or even death. Anthony noted that his son had only received the MenACWY vaccine at 14, which protects against four different bacteria, but not MenB.

Advocacy for Improved Awareness and Prevention

Becca Heritage, who lost her legs and a hand to MenB while studying in Southampton, praised the updated guidance. She stressed that young people must be educated about the disease’s risks and the importance of vaccination. "Young people's lives are not expendable," she argued. "This vaccine is our best protection against a deadly illness."

"It's easy to think 'it'll never be me,' but all young people should know the signs and symptoms," Heritage added. "They need to take ownership of their health and understand which strains they’re protected against."

Prof Wei Shen Lim, chair of the JCVI advisory group, acknowledged the impact of meningitis cases. "Invasive meningococcal disease is rare but devastating," he said. "We’ve collaborated closely with charities, and their experiences were crucial in shaping this recommendation."

Dr Tom Nutt of Meningitis Now called the change a "significant moment" in the fight against the disease. "This step ensures more young people are shielded from its effects," he said, urging swift government action to implement the program.